Luvox, illustration of tablet form (not a photo of the actual pack)

Illustrative image.

Luvox

Fluvoxamine

Prescription required

$108.00

50mg · 3 × 60 tablets · 3 months supply

GenericGeneric medicine· By Perrigo

$36.00 per month

Strength

How long a supply?

1 month$36.00 a month
3 months$36.00 a month
6 months$36.00 a month
Supplied from Israel

Test mode: no payment is taken. View cart

Annual cost

$432a year at this pack size

Prescription required

Upload your prescription after ordering, or send it to our pharmacy team. We dispense only against a valid prescription.

50mg

100mg

FDA boxed warningSuicidality and antidepressant drugs

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Anyone considering the use of fluvoxamine maleate tablets or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Fluvoxamine maleate tablets are not approved for use in pediatric patients except for patients with obsessive compulsive disorder (OCD)

Increased risk of suicidal thinking and behavior in children, adolescents, and young adults taking antidepressants for major depressive disorder and other psychiatric disorders. Fluvoxamine maleate tablets are not approved for use in pediatric patients except those with obsessive compulsive disorder.

Read this with the rest of the clinical information

About Luvox

Overview

Luvox is a prescription medicine containing fluvoxamine, a selective serotonin reuptake inhibitor (SSRI). It is used to treat obsessions and compulsions in people with obsessive compulsive disorder (OCD). It is thought to work by reducing the reuptake of serotonin by nerve cells in the brain.

What it treats

- Obsessions and compulsions in patients with obsessive-compulsive disorder (OCD).

Safety information

Side effects

Common side effects include nausea, sleepiness, trouble sleeping, weakness, nervousness, indigestion, sweating, reduced appetite, shaking and vomiting. Sexual side effects may include ejaculation problems, reduced sex drive and difficulty reaching orgasm. Dry mouth, nasal symptoms, altered taste and frequent urination were also reported in patients with OCD. In children and adolescents with OCD, reported effects also included agitation, depression, painful periods, gas, increased activity and rash. Contact a doctor promptly for worsening mental health or suicidal thoughts, unusually elevated mood or activity (mania or hypomania), seizures, or new or worsening sexual problems. Other serious risks requiring medical attention include serotonin syndrome, angle-closure glaucoma, low blood sodium and abnormal bleeding. Seek urgent medical help for suicidal thoughts or a seizure. Serotonin syndrome can occur with fluvoxamine alone, but the risk is greater when it is taken with other medicines that affect serotonin. Bleeding risk increases when it is taken with aspirin, NSAIDs or other medicines that affect blood clotting. Older people may be at greater risk of low blood sodium. Stopping fluvoxamine abruptly can cause discontinuation symptoms. Talk to your prescriber before stopping treatment.

FDA boxed warning

Suicidality and antidepressant drugs

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Anyone considering the use of fluvoxamine maleate tablets or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Fluvoxamine maleate tablets are not approved for use in pediatric patients except for patients with obsessive compulsive disorder (OCD)

Increased risk of suicidal thinking and behavior in children, adolescents, and young adults taking antidepressants for major depressive disorder and other psychiatric disorders. Fluvoxamine maleate tablets are not approved for use in pediatric patients except those with obsessive compulsive disorder.

A boxed warning is the strongest warning the US Food and Drug Administration requires on a medicine label. Text is taken from the official label, with internal section references removed.

When to call your doctor

- Suicidal thoughts or behavior. - Worsening depression or unusual changes in behavior. - A seizure, or seizures happening more often. - Unusual bleeding.

If symptoms are severe or getting worse quickly, seek emergency care rather than waiting.

Before taking this medicine

Do not take Luvox (fluvoxamine) with tizanidine, thioridazine, alosetron or pimozide. Do not take it with an MAOI used to treat psychiatric disorders, or within 14 days of stopping one. You must also wait at least 14 days after stopping fluvoxamine before starting such an MAOI. Do not start fluvoxamine while receiving linezolid or intravenous methylene blue, because of the risk of serotonin syndrome. Fluvoxamine should be avoided in people with unstable epilepsy. Controlled epilepsy requires monitoring; treatment should be stopped if seizures occur or become more frequent. Other conditions requiring caution include bipolar disorder or a history of mania or hypomania, untreated narrow drainage angles in the eyes, liver impairment, and illnesses affecting circulation or how the body processes medicines. Screening for bipolar disorder and monitoring for worsening symptoms or suicidal thoughts are needed. Other medicines that increase serotonin can raise the risk of serotonin syndrome. Ramelteon should not be used with fluvoxamine, and combining it with diazepam is generally not advisable. Other benzodiazepines, clozapine, methadone, mexiletine, theophylline and warfarin require particular care. Aspirin, NSAIDs and other medicines affecting blood clotting can increase bleeding risk. Fluvoxamine can cause low blood sodium, particularly in older adults, and sexual dysfunction. Use during the third trimester of pregnancy may increase the risk of persistent high blood pressure in the newborn’s lungs and problems with breathing, temperature control, feeding, muscle tone, tremor or irritability. Children need weight and growth monitoring; long-term effects on growth, cognitive and behavioural development, and maturation have not been studied. Do not stop fluvoxamine abruptly, as discontinuation symptoms can occur.

Interactions

Fluvoxamine can interfere with enzymes that break down other medicines, potentially increasing their levels in the body. Tell your doctor if you take: • Carbamazepine: levels may rise and cause toxicity. • Sumatriptan: rare reports with SSRI antidepressants include weakness, unusually strong reflexes and poor coordination. Monitoring may be needed. • Tacrine: levels may rise, with nausea, vomiting, sweating and diarrhoea reported. • Tricyclic antidepressants: levels may rise significantly; your doctor may need to monitor blood levels. • Tryptophan supplements: severe vomiting has been reported with this combination. • Diltiazem: a slow heartbeat has been reported. • Propranolol or metoprolol: your doctor may need to adjust treatment.

Using Luvox

Dosing

Dosing is set by your prescriber. Each health care professional may prescribe medication differently according to a patient's medical history and condition, so follow the directions on your prescription label and speak to your doctor or pharmacist before changing anything.

Storage

Store below 25°C in a dry place, in the original pack, away from direct light and moisture. Do not keep it in a bathroom. Keep all medicines out of the sight and reach of children.

Clinical information on this page is summarised from the US FDA label FLUVOXAMINE MALEATE TABLET [APOTEX CORP] (DailyMed, retrieved 19 September 2026).

Patient information and references

Official and supporting information to read alongside advice from your prescriber or pharmacist.

Reviews

No reviews yet. Mail Order Drugs opened recently, and we publish reviews only from verified customers of this site, so this space stays empty until real ones arrive.

  • Every prescription order is checked by a licensed pharmacist before dispensing.
  • Payment pages are encrypted and card details never reach our servers.
  • We ship internationally, with cold-chain packing where a medicine needs it.

Related medicines